Related Experiment Video
Updated: Apr 22, 2026

Isolation of Murine Coronary Vascular Smooth Muscle Cells
Published on: May 30, 2016
Phenotypic modulation of mesenteric vascular smooth muscle cells from type 2 diabetic rats is associated with
Maria Alicia Carrillo-Sepulveda1, Takayuki Matsumoto
1Department of Physiology, Georgia Regents University, Augusta, GA, USA.
Aims:
Diabetes-induced vascular complications are associated with vascular smooth muscle cell (VSMC) phenotypic modulation, switching from a contractile to a synthetic-proliferative phenotype. Loss of caveolin-1 is involved with proliferation of VSMCs. We tested the hypothesis that mesenteric VSMCs from type 2 diabetic Goto-Kakizaki (GK) rat undergo phenotypic modulation and it is linked to decreased caveolin-1 expression.
Methods:
VSMCs were isolated from mesenteric arteries from GK rats and age-matched control Wistar rats. Western blotting was used to determine expression of target proteins such as caveolin-1, calponin (marker of differentiation), and proliferating cell nuclear antigen (PCNA, marker of proliferation). In addition, we measured intracellular reactive oxygen species (ROS) production using H2DCF-DA and activation of extracellular signal-regulated kinase (ERK1/2) by western blotting in VSMCs from GK stimulated with lipopolysaccharide (LPS), an endotoxin upregulated in diabetes.
Results:
Mesenteric VSMCs from diabetic GK rats exhibited decreased caveolin-1 and calponin expression and increased PCNA expression compared to control. Increased levels of ROS and phospho-ERK1/2 expression were also found in GK VSMCs. LPS augmented ROS and phosphorylated ERK1/2 levels to a greater extent in GK VSMCs than in control. Likewise, high glucose decreased caveolin-1 and calponin expression, increased PCNA expression and augmented ROS production in control mesenteric VSMCs.
Conclusion:
These results suggest that mesenteric VSMCs from diabetic GK rats undergo phenotypic modulation and it is associated with decreased caveolin-1 expression. These alterations may be due to enhanced inflammatory stimuli and glucose levels present in diabetic milieu.
Insights
Diabetic mesenteric vascular smooth muscle cells (VSMCs) show reduced caveolin-1, promoting a proliferative phenotype. This vascular smooth muscle cell modulation is linked to increased inflammation and glucose levels in diabetes.
Area of Science:
- Vascular Biology
- Cellular Metabolism
- Diabetes Complications
Background:
- Vascular smooth muscle cell (VSMC) phenotypic modulation contributes to diabetes-associated vascular complications.
- Loss of caveolin-1 expression is implicated in VSMC proliferation.
Purpose of the Study:
- To investigate if mesenteric VSMCs from type 2 diabetic Goto-Kakizaki (GK) rats exhibit phenotypic modulation linked to decreased caveolin-1 expression.
- To explore the role of inflammatory stimuli and glucose in these diabetic vascular changes.
Main Methods:
- Isolated mesenteric VSMCs from GK and Wistar rats.
- Western blotting for caveolin-1, calponin, and PCNA.
- Assessed reactive oxygen species (ROS) and ERK1/2 activation.
Main Results:
- Diabetic GK rat VSMCs showed reduced caveolin-1 and calponin, increased PCNA, elevated ROS, and phospho-ERK1/2.
- LPS and high glucose exacerbated these changes in VSMCs.
Conclusions:
- Mesenteric VSMCs in diabetic GK rats undergo phenotypic modulation associated with decreased caveolin-1.
- Enhanced inflammation and glucose levels likely drive these diabetic vascular alterations.
More Related Videos
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction